⌘K

Home/Filings/4/0001209191-23-022045

4//SEC Filing

Carnes Martha Z. 4

Accession 0001209191-23-022045

CIK 0001000229other

View on SEC.gov Company Profile

Filed

Apr 2, 8:00 PM ET

Accepted

Apr 3, 1:32 PM ET

Size

9.1 KB

Accession

0001209191-23-022045

Insider Transaction Report

Form 4

Period: 2023-04-01

CORE LABORATORIES N VCLB

Carnes Martha Z.

Director

Transactions

Exercise/Conversion
Common Shares
2023-04-01+5,485→ 30,592 total
Award
Restricted Shares
2023-04-01+6,419→ 6,419 total
Exercise: $0.00→ Common Shares (6,419 underlying)
Exercise/Conversion
Restricted Shares
2023-04-01−5,485→ 0 total
Exercise: $0.00→ Common Shares (5,485 underlying)

Footnotes (2)

[F1]The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2024, subject to the terms of issuance.
[F2]The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2023.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1

filerCIK 0001678397

Filing Metadata

Form type: 4
Filed: Apr 2, 8:00 PM ET
Accepted: Apr 3, 1:32 PM ET
Size: 9.1 KB

View on SEC.gov